E. Gladstone

发表

Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib

B. Taylor, M. Ladanyi, A. Drilon, 2020, Clinical Cancer Research.

Empirical Complexities in the Genetic Foundations of Lethal Mutagenesis

J. Bull, P. Joyce, I. Molineux, 2013, Genetics.

The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions

M. Ladanyi, R. Somwar, E. de Stanchina, 2021, Clinical Cancer Research.

RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation

M. Ladanyi, A. Drilon, E. Cheng, 2020, Disease Models & Mechanisms.

Evolutionary principles and synthetic biology: avoiding a molecular tragedy of the commons with an engineered phage

J. Bull, I. Molineux, E. Gladstone, 2012, Journal of biological engineering.

Establishment of multiple novel patient-derived models of desmoplastic small round cell tumor enabling functional characterization of ERBB pathway signaling and pre-clinical evaluation of a novel targeted therapy approach

M. Ladanyi, C. Pratilas, R. Somwar, 2020, bioRxiv.

Novel patient-derived models of DSRCT enable validation of ERBB signaling as a potential therapeutic vulnerability.

M. Ladanyi, C. Pratilas, R. Somwar, 2021, Disease Models & Mechanisms.

Gene Discovery in Loblolly Pine Through cDNA Sequencing

C. Baysdorfer, S. Gerttula, D. Harry, 1996 .